Urinary Bladder, Overactive: Clinical Trials

14 trials for Urinary Bladder, Overactive, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

14 unknown. 14 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	14	Unknown 14

Follow Urinary Bladder, Overactive: new trials by email Literature Review of Urinary Bladder, Overactive trials Research Report on Urinary Bladder, Overactive

Trials (filtered) newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Mirabegron Combined With Behavioral Intervention for Overactive Bladder：a Prospective Multicenter Randomized Controlled Clinical Study mirabegron - Overactive Bladder	Phase 4	Unknown	Peking Union Medical College Hospital	600	2022-07-15	2022-07-11
Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial OnabotulinumtoxinA - Overactive Bladder Syndrome, Overactive Bladder	Phase 4	Unknown	Augusta University	100	2022-01-01	2021-12-15
Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia. Mirabegron, Tamsulosin - Overactive Bladder, Benign Prostatic Hyperplasia	Phase 4	Unknown	St. Joseph's Healthcare Hamilton	200	2021-12-01	2021-03-19
Sequencing and Combination of Mirabegron and TTNS in Overactive Bladder Syndrome: a Multicenter, Randomized, Open-label, Crossover Trial mirabegron, TTNS - Overactive Bladder Syndrome	Phase 4	Unknown	Taipei Veterans General Hospital, Taiwan	180	2021-11-10	2022-01-12
Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB Tadalafil 5mg, Tamsulosin Hcl 0.4 mg, solifenacin 10 mg - Benign Prostatic Hyperplasia, Overactive Bladder	Phase 4	Unknown	Mansoura University	60	2021-11-08	2022-08-10
BOTOX® at the Time of Prolapse Surgery for OAB OnabotulinumtoxinA 100 UNT, Injectable saline - Urinary Bladder, Overactive, Pelvic Organ Prolapse	Phase 4	Unknown	Walter Reed National Military Medical Center	138	2021-09-23	2021-10-14
Oral vs Intravesical Analgesia for Office Bladder Botox Injections Phenazopyridine, Lidocaine 2% Injectable Solution - Overactive Bladder Syndrome, Urge Incontinence	Phase 4	Unknown	Women and Infants Hospital of Rhode Island	110	2018-11-01	2020-05-29
Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease Mirabegron, Placebo - Overactive Bladder, Parkinson Disease	Phase 4	Unknown	Seoul National University Hospital	144	2017-07-17	2018-01-30
MIrabegron With oveRACtive bLadder Symptoms in mEn mirabegron, placebo - Overactive Bladder	Phase 4	Unknown	Seoul National University Hospital	462	2015-02-01	2015-02-11
Botulinum Toxin in the Treatment of Idiopathic Detrusor Overactivity Botulinum toxin injected to bladder body, Botulinum toxin injected into trigone - Overactive Detrusor	Phase 4	Unknown	Mr HD Flood	60	2013-12-01	2013-12-12
Premarin Versus Toviaz for Treatment of Overactive Bladder Toviaz, Premarin, Placebo cream - Overactive Bladder	Phase 4	Unknown	The Cleveland Clinic	90	2012-04-01	2017-04-20
Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder Solifenacin, Oxybutynin - Overactive Bladder	Phase 4	Unknown	Adana Numune Training and Research Hospital	500	2011-09-01	2011-08-26
Botulinum A Toxin in Patients With Parkinson's Disease Intravesical injection of Botulinum A toxin - Parkinson's Disease, Multiple System Atrophy	Phase 4	Unknown	University Of Perugia	20	2008-06-01	2009-01-15
Assessing the OAB-8 Questionnaire as a Tool to Measure Treatment Outcome DETRUSITOL - Overactive Bladder	Phase 4	Unknown	Rambam Health Care Campus	100	2006-02-01	2007-02-21

Narrower conditions

Broader conditions

Interventions

Sponsors

Countries

Top investigators

Results publications